14-day Premium Trial Subscription Try For FreeGet Free
Currently predicting for Tue, 5 Dec 2023

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.85 4.65 %
R2 5.74 2.60 %
R1 5.66 1.33 %
Current price: 5.59
Support S1 5.44 -2.76 %
S2 5.36 -4.03 %
S3 5.25 -6.08 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 5.85 4.65 %
R2 5.70 1.97 %
R1 5.60 0.179 %
Current price 5.59
Support S1 5.20 -6.98%
S2 4.86 -13.06%
S3 4.72 -15.56%

CASI Predictions History

1 year ago
Pavel Kupershtoh predicted that CASI for 2022-08-01 is going

Rank:

2 years ago
JS predicted that CASI for 2020-12-22 is going $2.83 (-7.82%)

2 years ago
JS predicted that CASI for 2020-12-21 is going $2.75 (-5.50%)

4 years ago
NameNotImportant predicted that CASI for 2019-05-02 is going $3.15 (-3.37%)

5 years ago
JS predicted that CASI for 2018-01-23 is going $4.10 (-1.20%)

5 years ago
Jacob.Astorian.16808 predicted that CASI for 2018-01-19 is going $7.00 (75.88%)

Rank:

5 years ago
Balagurubaran predicted that CASI for 2017-12-13 is going $2.70 (0.75%)

Rank:
Click to get the best stock tips daily for free!

About CASI Pharmaceuticals

CASI Pharmaceuticals CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T inve... CASI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT